博晖创新(300318)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300318 博晖创新

已收盘 09-29 15:00:00

{"stockData":{"symbol":"300318","market":"SZ","secType":"STK","nameCN":"博晖创新","latestPrice":5.14,"timestamp":1790665428000,"preClose":5.17,"halted":0,"volume":8002869,"delay":0,"changeRate":-0.0058,"floatShares":799000000,"shares":817000000,"eps":-0.1088,"marketStatus":"已收盘","change":-0.03,"latestTime":"09-29 15:00:00","open":5.17,"high":5.24,"low":5.12,"amount":41414700,"amplitude":0.0232,"askPrice":5.15,"askSize":842,"bidPrice":5.14,"bidSize":637,"shortable":0,"etf":0,"ttmEps":-0.1088,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790731800000},"marketStatusCode":5,"adr":0,"adjPreClose":5.17,"symbolType":"stock","openAndCloseTimeList":[[1790645400000,1790652600000],[1790658000000,1790665200000]],"highLimit":5.69,"lowLimit":4.65,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":816900495,"isCdr":false,"pbRate":3.32,"roa":"--","roe":"--","epsLYR":-0.1125,"committee":-0.237834,"marketValue":4199000000,"turnoverRate":0.01,"status":1,"floatMarketCap":4104000000},"requestUrl":"/m/hq/s/300318/","defaultTab":"news","newsList":[{"id":"2667504692","title":"博晖创新：云南博晖已具备人血白蛋白生产条件","url":"https://stock-news.laohu8.com/highlight/detail?id=2667504692","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667504692?lang=zh_cn&edition=full","pubTime":"2026-09-15 08:51","pubTimestamp":1789433468,"startTime":"0","endTime":"0","summary":"2、公司控股孙公司云南博晖已经获批静注人免疫球蛋白《药品补充申请批准通知书》，目前正在等待云南省药监局颁发《药品GMP符合性检查告知书》及《药品生产许可证》，待完成后，云南博晖将具备静注人免疫球蛋白生产条件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500006713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","BK0251","300318","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663025551","title":"股市必读：博晖创新新发布《关于曲靖血液制品生产基地进展的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2663025551","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663025551?lang=zh_cn&edition=full","pubTime":"2026-08-31 09:22","pubTimestamp":1788139363,"startTime":"0","endTime":"0","summary":"公司公告汇总关于曲靖血液制品生产基地进展的公告北京博晖创新生物技术集团股份有限公司控股孙公司博晖生物制药（云南）有限公司投资13.8亿元建设曲靖血液制品生产基地，已完成人血白蛋白的上市许可持有人及生产场地变更，并取得国家药监局和云南省药监局的相关批准证书，具备人血白蛋白生产条件。河北博晖2025年人血白蛋白销售收入约15994.36万元，占公司全年收入19.40%。云南博晖将于近日正式投产，并持续推进其他品种的产业化生产。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100003673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300318","BK0251","BK0048","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662747037","title":"股市必读：博晖创新新发布《2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662747037","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662747037?lang=zh_cn&edition=full","pubTime":"2026-08-27 05:49","pubTimestamp":1787780952,"startTime":"0","endTime":"0","summary":"公司公告汇总：2026年半年度报告摘要显示，归母净利润为-15,606,630.04元，同比上升16.49%；经营活动现金流量净额为-36,650,410.85元，同比改善27.59%。第九届董事会第二次会议决议公告北京博晖创新生物技术集团股份有限公司于2026年8月25日召开第九届董事会第二次会议，审议通过《2026年半年度报告》及其摘要。非经营性资金占用及其他关联资金往来情况汇总表截至2026年6月末，公司与控股股东、实际控制人及其附属企业之间无非经营性资金占用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0251","300318","BK0048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662758456","title":"博晖创新（300318）披露2026年半年度报告，8月25日股价上涨3.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662758456","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662758456?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:14","pubTimestamp":1787667263,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，博晖创新报收于5.05元，较前一交易日上涨3.7%，最新总市值为41.25亿元。该股当日开盘4.84元，最高5.07元，最低4.81元，成交额达8112.01万元，换手率为2.03%。近日，博晖创新披露《2026年半年度报告》。本报告期末总资产为4,390,580,020.84元，较上年度末的4,304,243,808.48元增长2.01%；归属于上市公司股东的净资产为1,271,761,949.08元，较上年度末的1,285,185,304.19元下降1.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500050429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300318","BK0251","BK0048","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662947739","title":"博晖创新(300318.SZ)发布上半年业绩，归母净亏损1560.66万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662947739","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662947739?lang=zh_cn&edition=full","pubTime":"2026-08-25 19:14","pubTimestamp":1787656484,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博晖创新 发布2026年半年度报告，报告期内，公司实现营业收入3.96亿元，同比下降2.09%。归属于上市公司股东净亏损1560.66万元，归属于上市公司股东的扣除非经常性损益净亏损1481.99万元。报告期内，公司体外诊断主要销售产品为人体微量元素检测及HPV检测，终端用户为医院和第三方检测机构。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300318","BK0251","BK0028","BK0048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662717733","title":"图解博晖创新中报：第二季度单季净利润同比增长43.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662717733","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662717733?lang=zh_cn&edition=full","pubTime":"2026-08-25 18:16","pubTimestamp":1787653016,"startTime":"0","endTime":"0","summary":"证券之星消息，博晖创新2026年中报显示，上半年度公司主营收入3.96亿元，同比下降2.09%；归母净利润-1560.66万元，同比上升16.49%；扣非净利润-1481.99万元，同比上升24.38%；其中2026年第二季度，公司单季度主营收入2.06亿元，同比上升1.66%；单季度归母净利润-832.14万元，同比上升43.14%；单季度扣非净利润-799.06万元，同比上升45.48%；负债率51.06%，投资收益-69.13万元，财务费用1918.81万元，毛利率32.78%。财报数据概要请见下图:本文数据来源于博晖创新2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500038780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300318"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662738239","title":"博晖创新(300318)6月30日股东户数2.93万户，较上期减少8.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662738239","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662738239?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:52","pubTimestamp":1787651561,"startTime":"0","endTime":"0","summary":"证券之星消息，近日博晖创新披露，截至2026年6月30日公司股东户数为2.93万户，较3月31日减少2706.0户，减幅为8.46%。在生物制品行业个股中，博晖创新股东户数低于行业平均水平，截至6月30日，生物制品行业平均股东户数为3.55万户。从股价来看，2026年3月31日至2026年6月30日，博晖创新区间跌幅为28.55%，在此期间股东户数减少2706.0户，减幅为8.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500037640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300318","BK0028","BK0048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431528","title":"股市必读：博晖创新（300318）8月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431528","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660431528?lang=zh_cn&edition=full","pubTime":"2026-08-18 01:34","pubTimestamp":1786988099,"startTime":"0","endTime":"0","summary":"截至2026年8月17日收盘，博晖创新报收于5.11元，下跌0.97%，换手率1.13%，成交量8.97万手，成交额4572.09万元。董秘最新回复投资者： 公司的微流控芯片及检测分析仪器均为自研。当日关注点交易信息汇总：8月17日主力资金净流出380.87万元，占总成交额8.33%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800001868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","300318","BK0028","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660486453","title":"公司问答丨博晖创新：公司实现了小型台式质谱仪的国内生产 并推向科研用户市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2660486453","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660486453?lang=zh_cn&edition=full","pubTime":"2026-08-17 17:39","pubTimestamp":1786959555,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0048","BK0251","300318","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483461","title":"博晖创新：分子诊断和免疫诊断优势互补","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483461","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660483461?lang=zh_cn&edition=full","pubTime":"2026-08-17 16:30","pubTimestamp":1786955430,"startTime":"0","endTime":"0","summary":"证券之星消息，博晖创新08月17日在投资者关系平台上答复投资者关心的问题。公司当前拥有的技术平台主要包括分子诊断、免疫诊断、原子吸收和质谱。分子诊断和免疫诊断主要进行病原体检测，分子诊断具有更高的灵敏度和特异性，免疫诊断具有时间短、操作方便等优点，两个诊断平台优势互补，面向不同的使用场景。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700020609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300318","BK0028","BK0048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483405","title":"博晖创新：相关的核心零部件也均已完全实现国产化","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483405","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660483405?lang=zh_cn&edition=full","pubTime":"2026-08-17 16:30","pubTimestamp":1786955430,"startTime":"0","endTime":"0","summary":"证券之星消息，博晖创新(300318)08月17日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的微流控芯片及检测分析仪器均为自研。请问核心芯片设计与制造、配套仪器的核心零部件，是否已完全实现国产化？有无卡脖子风险？博晖创新回复：尊敬的投资者，您好！目前，公司基于微流控技术相关产品的设计和加工制造均在国内实现，相关的核心零部件也均已完全实现国产化，目前无卡脖子风险。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700020607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300318","BK0251","BK0028","BK0048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660836714","title":"博晖创新：层析工艺静丙已有中长期研发规划","url":"https://stock-news.laohu8.com/highlight/detail?id=2660836714","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660836714?lang=zh_cn&edition=full","pubTime":"2026-08-17 16:27","pubTimestamp":1786955240,"startTime":"0","endTime":"0","summary":"证券之星消息，博晖创新(300318)08月17日在投资者关系平台上答复投资者关心的问题。投资者提问：血液制品板块的技术升级：公司正推动云南血制基地投产。在血液制品领域，是否有布局新一代技术（如层析法静丙、重组人白蛋白等）的规划？博晖创新回复：尊敬的投资者，您好！公司持续关注行业前沿技术发展方向，在新一代技术布局方面，层析工艺静丙已有中长期研发规划，并按计划推进。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700020520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0028","BK0048","300318"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660839134","title":"博晖创新：人用狂犬病疫苗采用原代地鼠肾细胞培养","url":"https://stock-news.laohu8.com/highlight/detail?id=2660839134","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660839134?lang=zh_cn&edition=full","pubTime":"2026-08-17 16:27","pubTimestamp":1786955235,"startTime":"0","endTime":"0","summary":"证券之星消息，博晖创新08月17日在投资者关系平台上答复投资者关心的问题。谢谢博晖创新回复：尊敬的投资者，您好！博晖生物制药股份有限公司主要从事疫苗产品的研发、生产和销售，目前已上市销售的产品人用狂犬病疫苗采用原代地鼠肾细胞培养，无致瘤风险；生产工艺成熟，不含佐剂与硫柳汞，安全性良好；接种后起效迅速且保护持久。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700020510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0048","300318","BK0028","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483996","title":"博晖创新：推出医疗用ICP-MS及配套试剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483996","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660483996?lang=zh_cn&edition=full","pubTime":"2026-08-17 16:27","pubTimestamp":1786955226,"startTime":"0","endTime":"0","summary":"证券之星消息，博晖创新(300318)08月17日在投资者关系平台上答复投资者关心的问题。投资者提问：公司2015年收购美国Advion进入质谱领域。国内团队的研发进展如何。谢谢博晖创新回复：尊敬的投资者，您好！公司已经在国内市场推出了专用于医疗领域的电感耦合等离子体质谱仪（ICP-MS）及配套试剂，目前正在市场拓展中；同时，公司也实现了小型台式质谱仪的国内生产，并推向科研用户市场。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700020506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300318","159891","BK0048","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651146373","title":"股市必读：博晖创新（300318）7月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2651146373","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651146373?lang=zh_cn&edition=full","pubTime":"2026-07-14 01:50","pubTimestamp":1783965021,"startTime":"0","endTime":"0","summary":"截至2026年7月13日收盘，博晖创新报收于4.57元，上涨0.44%，换手率1.18%，成交量9.32万手，成交额4247.04万元。董秘最新回复投资者： 请公布一下6月30日最新股东人数，请精确到个位数，谢谢董秘： 尊敬的投资者，您好!公司截止2026年6月30日股东人数可关注公司将于2026年8月26日披露的《2026年半年度报告》，感谢您的关注!当日关注点交易信息汇总：7月13日主力资金净流入425.23万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400001385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","300318","BK0028","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646879831","title":"博晖创新（300318）披露2025年度股东会决议公告，6月25日股价下跌1.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646879831","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646879831?lang=zh_cn&edition=full","pubTime":"2026-06-25 17:38","pubTimestamp":1782380330,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘，博晖创新报收于4.34元，较前一交易日下跌1.36%，最新总市值为35.45亿元。该股当日开盘4.38元，最高4.39元，最低4.24元，成交额达3405.57万元，换手率为1.0%。博晖创新于近日披露《2025年度股东会决议公告》。会议采用现场与网络投票结合方式召开，表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500032445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0048","BK0251","300318"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640155640","title":"博晖创新：公司目前正积极开拓海外市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2640155640","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640155640?lang=zh_cn&edition=full","pubTime":"2026-06-04 17:09","pubTimestamp":1780564145,"startTime":"0","endTime":"0","summary":"证券之星消息，博晖创新(300318)06月04日在投资者关系平台上答复投资者关心的问题。投资者提问：贵单位的各类试剂盒有没有海外销售渠道？博晖创新回复：尊敬的投资者，您好！公司目前正积极开拓海外市场，通过参加海外展会、与相关代理渠道建立协作、面向海外的在线商城等多种方式，逐步建设多层次的海外销售渠道。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400029423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0048","300318","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638542956","title":"股市必读：博晖创新（300318）今年截至5月26日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638542956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638542956?lang=zh_cn&edition=full","pubTime":"2026-05-27 02:49","pubTimestamp":1779821350,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，博晖创新报收于5.11元，下跌1.54%，换手率0.72%，成交量5.7万手，成交额2904.29万元。当日关注点来自交易信息汇总：博晖创新股价已连续7日下跌，当年累计跌幅达25.99%。交易信息汇总5月26日博晖创新收盘报5.11元，跌1.54%，当日成交570.43万元。前10个交易日主力资金累计净流出3166.48万元，股价累计下跌16.66%。资金流向5月26日主力资金净流出298.21万元；游资资金净流入127.66万元；散户资金净流入170.55万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700002226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0048","300318","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636896019","title":"股市必读：博晖创新（300318）今年截至5月15日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636896019","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636896019?lang=zh_cn&edition=full","pubTime":"2026-05-18 04:42","pubTimestamp":1779050533,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，博晖创新报收于5.33元，下跌0.74%，换手率0.86%，成交量6.78万手，成交额3630.47万元。当日关注点来自交易信息汇总：博晖创新股价已连续5日下跌，当年累计跌幅达20.42%。交易信息汇总股价提醒5月15日博晖创新收盘报5.33元，跌0.74%，当日成交678.25万元。前10个交易日资金流向情况：主力资金累计净流出3147.16万元，股价累计下跌10.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800001919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300318","BK0251","BK0048","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630360375","title":"博晖创新(300318.SZ)发布一季度业绩，归母净亏损728.52万元，扩大79.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630360375","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630360375?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:36","pubTimestamp":1777286175,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博晖创新(300318.SZ)发布2026年第一季度报告，该公司营业收入为1.9亿元，同比减少5.85%。归属于上市公司股东的净亏损为728.52万元，同比扩大79.68%。归属于上市公司股东的扣除非经常性损益的净亏损为682.93万元，同比扩大38.20%。基本每股亏损为0.0089元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434547.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300318","BK0048","BK0028","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790715683664,"stockEarnings":[{"period":"1week","weight":-0.0115},{"period":"1month","weight":0},{"period":"3month","weight":0.1629},{"period":"6month","weight":-0.149},{"period":"1year","weight":-0.0789},{"period":"ytd","weight":-0.1802}],"compareEarnings":[{"period":"1week","weight":-0.0308},{"period":"1month","weight":-0.0308},{"period":"3month","weight":-0.0686},{"period":"6month","weight":-0.0227},{"period":"1year","weight":-0.0083},{"period":"ytd","weight":-0.0349}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京博晖创新生物技术集团股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"29261人(较上一季度减少8.46%)","perCapita":"27290股","listingDate":"2012-05-23","address":"北京市昌平区生命园路9号院","registeredCapital":"81690万元","survey":"　　北京博晖创新生物技术集团股份有限公司的主营业务是体外诊断产品的研发、生产与销售。公司的主要产品是检验仪器、检测试剂。","listedPrice":15},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博晖创新(300318)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博晖创新(300318)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博晖创新,300318,博晖创新股票,博晖创新股票老虎,博晖创新股票老虎国际,博晖创新行情,博晖创新股票行情,博晖创新股价,博晖创新股市,博晖创新股票价格,博晖创新股票交易,博晖创新股票购买,博晖创新股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博晖创新(300318)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博晖创新(300318)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}